scholarly journals Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study

2008 ◽  
Vol 6 (1) ◽  
pp. 75 ◽  
Author(s):  
Dennis A Revicki ◽  
Alan Menter ◽  
Steven Feldman ◽  
Miriam Kimel ◽  
Neesha Harnam ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document